Axim Biotechnologies Inc - ESG Rating & Company Profile powered by AI
This ESG rating for Axim Biotechnologies Inc indicates its reporting of the United Nations SDGs. The Disclosure rating includes seventeen United Nations SDGs including: 'Quality Education', 'Responsible Production & Consumption' and 'Life on Land'. Detailed Sustainability analysis of Axim Biotechnologies Inc can be reached by registering for free.
Axim Biotechnologies Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Axim Biotechnologies Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Axim Biotechnologies Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Axim Biotechnologies Inc report the average age of the workforce?
Sign up for free to unlockDoes Axim Biotechnologies Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Axim Biotechnologies Inc offer flexible work?
Sign up for free to unlockDoes Axim Biotechnologies Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Axim Biotechnologies Inc conduct supply chain audits?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Axim Biotechnologies Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose water use targets?
Sign up for free to unlockDoes Axim Biotechnologies Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Axim Biotechnologies Inc have a product recall in the last two years?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Axim Biotechnologies Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Axim Biotechnologies Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose parental leave metrics?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Axim Biotechnologies Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Axim Biotechnologies Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Axim Biotechnologies Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose its waste policy?
Sign up for free to unlockDoes Axim Biotechnologies Inc report according to TCFD requirements?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose energy use targets?
Sign up for free to unlockDoes Axim Biotechnologies Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Axim Biotechnologies Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Axim Biotechnologies Inc
These potential risks are based on the size, segment and geographies of the company.
AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. The company is developing rapid diagnostic tests, which measure the levels of functional neutralizing antibodies that prevent SARS-CoV-2 from attaching to human cells; serological diagnostic test, which detect neutralizing antibodies that measure adaptive immune response to the SARS-CoV-2 virus; and tests for management of COVID-19 Patients to detect biomarkers related to inflammation. It is also developing rapid quantitative tear tests for Matrix metalloproteinase-9, an inflammatory biomarker for dry eye disease; SBI-183, an anti-metastatic compound suppressing tumor cell growth and blocking metastasis; and SPX-1009, an anti-metastatic treatment to measure levels of quiescin sulfhydryl oxidase I. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.